Vaxart, Inc.
VXRT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000072444
No open-market purchases or sales by Vaxart, Inc. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $39.0K in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Vaxart, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 143 | 2 | 132 | −9 |
| Shares | 50.8M | 8.00K | 44.3M | −6.45M (−12.7%) |
| Value | $110.7M | $17.0K | $42.6M | −$68.1M (−61.5%) |
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Vaxart, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ergoteles LLC | 1,040,648 | $1.00M | 0.04% |
| Renaissance Technologies LLC | 1,011,816 | $972.0K | 0.00% |
| HRT Financial LP | 544,239 | $522.0K | 0.01% |
| Alpine Global Management, LLC | 128,354 | $123.0K | 0.04% |
| Y-Intercept (Hong Kong) Ltd | 125,502 | $120.6K | 0.02% |
| Quantbot Technologies LP | 72,400 | $69.6K | 0.00% |
| RMB Capital Management, LLC | 41,701 | $40.1K | 0.00% |
| Centiva Capital, LP | 38,563 | $37.0K | 0.00% |
| CI Private Wealth, LLC | 18,325 | $17.6K | 0.00% |
| Bleakley Financial Group, LLC | 13,788 | $13.2K | 0.00% |
| StoneX Group Inc. | 10,931 | $10.5K | 0.00% |
| Dark Forest Capital Management LP | 7,220 | $6.94K | 0.00% |
| Federated Hermes, Inc. | 2,800 | $2.69K | 0.00% |
| Belpointe Asset Management LLC | 2,466 | $2.37K | 0.00% |
| Cary Street Partner Investment Advisory LLC | 1,000 | $961 | 0.00% |
| Advisory Services Network, LLC | 500 | $480 | 0.00% |
| Money Concepts Capital Corp | 150 | $144 | 0.00% |
| Concord Wealth Partners | 75 | $72 | 0.00% |
| ICA Group Wealth Management, LLC | 50 | $54 | 0.00% |
| CoreCap Advisors, LLC | 4 | $4 | 0.00% |
| Pathstone Family Office, LLC | 860 | – | – |
Sold out (30)
Institutions that held Vaxart, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
Not filed for Q4 2022 yet (2)
Institutions that held Vaxart, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Strategic Asset Management, LLC | 6,000 | $13.0K |
| Wipfli Financial Advisors LLC, | 2,000 | $4.00K |